IMMUNE DESIGN CORP COMMON STOCK (IMDZ) Covered Calls

Immune Design Corp is a clinical stage immuno-therapy company with next-generation in vivo approaches designed to enable the body's immune system to fight disease.

You can sell covered calls on IMMUNE DESIGN CORP COMMON STOCK to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for IMDZ (prices last updated Fri 4:16 PM ET):

IMMUNE DESIGN CORP COMMON STOCK (IMDZ) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.66 0.00 1.61 1.70 1.1M - 0.1B
Covered Calls For IMMUNE DESIGN CORP COMMON STOCK (IMDZ)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 2.5 0.00 1.70 0.0% 0.0%
Dec 21 2.5 0.10 1.60 6.2% 35.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Immune Design Corp. is a clinical-stage immunotherapy company, which develops vivo approaches designed to enable the body's immune system to fight disease. It develops two discovery platforms, DCVex and GLAAS. The company products include LV305, CMB305 and G100, which are in Phase 1 clinical trials. Immune Design was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Seattle, WA.